Sagimet Biosciences
SGMT
SGMT
86 hedge funds and large institutions have $85.2M invested in Sagimet Biosciences in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5.68% more ownership
Funds ownership: 40.76% → 46.43% (+5.7%)
2% less capital invested
Capital invested by funds: $86.7M → $85.2M (-$1.46M)
Holders
86
Holding in Top 10
1
Calls
$1.9M
Puts
$1.31M
Top Buyers
| 1 | +$5.74M | |
| 2 | +$5.61M | |
| 3 | +$2.19M | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$1.59M |
| 5 |
BlackRock
New York
|
+$1.45M |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$3.59M | |
| 3 | -$2.23M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.55M |
| 5 |
Millennium Management
New York
|
-$1.36M |
